Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    


Vertex Pharmaceuticals Incorporate (VRTX)
$63.38 -1.32 (-2.04%)   May 15

130 Waverly Street , Cambridge,  MA  02139 , USA
+1-617-444-6100
  http://www.vrtx.com/
PRICES
VALUATIONS
RATIOS
STOCKHOLDERS
Open
Volume
Mkt Cap

P/E
EPS (prev. yr)
Dividend
Yield
64.37
4.01M
12899

452.71
0.14
n/a
n/a
High
Low
52wk    High
52wk
Low
BV
P/BV
Outstanding Shares

66.10
62.88
64.70
26.60
2.48
25.56
203.52

You need to upgrade your Flash Player
Chart Type: Line - Basic Comparison OHLC Candlestick Smooth


amcolumn
You need to upgrade your Flash Player


You need to upgrade your Flash Player

Financial Summary (In millions of USD)
2003
2004
2005
2006
2007
2008
2009
2010
Income Statement
Total Revenue
$69.14
$102.72
$160.89
$216.36
$199.01
$175.50
$101.89
$143.37
Operating Income
$-264.53
$-154.81
$-149.87
$-229.04
$-419.79
$-462.71
$-614.01
$-696.08
Net Income
$-196.77
$-166.25
$-203.42
$-206.89
$-391.28
$-459.85
$-642.18
$-754.63
Balance Sheet
Total Assets
$724.41
$545.45
$549
$921.58
$601.48
$980.48
$1,955.49
$1,725.45
Total Equity
$192.84
$35.44
$239.18
$505.94
$271.30
$238.87
$1,096.35
$503.97
Total Liabilities
$531.57
$510.01
$309.82
$415.64
$330.18
$741.61
$859.14
$1,221.47
Cash Flow
Operating
$-167.62
$-142.12
$-172.05
$-22.48
$-252.48
$-226.48
$-427.59
$-635.44
Investing
$119.58
$107.39
$-1.73
$-208.47
$405.17
$-360.65
$-508.73
$7.30
Financing
$37.47
$-8.63
$197.46
$365.87
$-10.19
$620.74
$999.01
$425.06
Net Cash Change
$-9.94
$-43.15
$23.04
$135.13
$142.49
$33.45
$57.54
$-203.46

Earnings Calls Calendar
2010
2009
2008
2007
2006
04 February 2010
21 April 2010
28 July 2010
25 October 2010
09 February 2009
16 April 2009
05 August 2009
26 October 2009
11 February 2008
21 April 2008
31 July 2008
27 October 2008
01 February 2007
30 April 2007
13 June 2007
24 July 2007
29 October 2007
26 July 2006
26 October 2006

Earnings Calls Summary
 Transcripts

10K Reports
 Annual Reports

123Jump News
13 November 2002


Management
Executive
Title
Charles A. Sanders
Chairman of the Board
Joshua S. Boger
President, Chief Executive Officer, Director
Richard C. Garrison
Senior Vice President, Catalyst
Lisa Kelly
Senior Vice President of Human Resources
Kenneth S. Boger
Senior Vice President, General Counsel
Peter Mueller
Executive Vice President- Drug Innovation and Realization, Chief Scientific Officer
Kurt C. Graves
Executive Vice President, Chief Commercial Officer and Head of Strategic Development
John J. Alam
Executive Vice President- Medicines Development, Chief Medical Officer
Ian F. Smith
Chief Financial Officer, Executive Vice President
Amit K. Sachdev
Senior Vice President - Public Policy and Government Affairs



Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2012 123jump.com. All rights reserved